Drug Research
CDMOs to benefit from rising BTDs, orphan drugs and fast track status
CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th – 7th November 2019) – has released the fourth part of its eponymous 2019 annual Report. Experts Peter Soelkner, Managing Director, Vetter Pharma International GmbH, Stewart...
News
Anaqua Lands Patent Management Deal with the U.S. Army Medical Research and Development Command
Anaqua, the leading provider of innovation and intellectual property management solutions, announced that the U.S. Army Medical Research and Development Command (USAMRDC) has selected the ANAQUA platform to manage its global IP portfolio.
The USAMRDC is the Army's medical materiel...
Drug Research
Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis in the U.S.
Zürich, Switzerland. Bioeq IP AG has announced that it signed a license and development agreement with Coherus BioSciences, Inc. , under which Coherus will exclusively market and distribute Bioeq’s biosimilar candidate to Lucentis in the United States (U.S.).
Bioeq will...
News
CPhI Worldwide announces the winners of the 16th Pharma Awards
CPhI Worldwide, organised by Informa PLC, announce the winners of the prestigious 2019 CPhI Pharma Awards – celebrating the industry’s top innovators, performers and outstanding achievements across 13 categories, spanning the entire industry supply chain. The winners have been...
News
PromoCell now offers in vitro disease models that could lead to new therapies
PromoCell, a premier manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes type 1 and 2, respiratory diseases such as COPD and asthma, as well as...
News
Aptar Pharmas Nanopharm Wins Excellence in Pharma Award for SmartTrack at 2019 CPhI Pharma Awards
Aptar Pharma, a leading drug delivery systems provider, announces that Nanopharm has won an Excellence in Pharma Award at the 2019 CPhI Pharma Awards. Nanopharm, an Aptar Pharma company and part of their expanded services offering, won in the...
News
GVK Bio continues to see growth tailwinds for 2020 thanks to a crescendo of factors
GVK Bio, the global Contract Research and Development Organisation (CRDO), announces that a crescendo of market conditions and a strong customer pipeline are colliding to deliver strong growth in 2020.
In the past few years the company has quickly consolidated...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















